Kicking off #SSO2024 at the TARPSWG meeting with Winan van Houdt giving an update on STRASS2 enrollment. #SarcomaSSO2024

Single dose of nivolumab before isolated limb perfusion #ILP for melanoma in-transit metastasis #ITM : a phase Ib/II trial doi.org/10.1016/j.ejso… Carl-Jacob Khailat Holmberg Lars Ny Winan van Houdt

PRADO - can't predict who will need CLND after index node biopsy in pts with cN+ melanoma yet. Maybe imaging will help in the future? #SSO2024 Winan van Houdt

front & center for MD Anderson Cancer Center and BWH Surgical Oncology moderators Jeffrey Gershenwald & Liz Lilley at the Society of Surgical Oncology Melanoma parallel session. Great presentations! #SSO2024 Amanda Kirane, MD Jonathan Zager, MD Sophia K. McKinley MD EdM Winan van Houdt

Looking back at a great visit MD Anderson Cancer Center thanks to Christina Roland, MD, MS: inspiring meetings with multidisciplinary leaders in the field of sarcoma and melanoma, journal club hosted by Kelly K Hunt for fellows and residents discussing STRASS2, and much more. It was a true pleasure!

I had a wonderful time Moffitt Cancer Center doing grand rounds, spending time with the surg onc fellows, meeting academic friends and collaborators and learn from each other. Special thanks to John E. Mullinax, MD, FACS and team for hosting me!

The best part of academic medicine is learning from the friends we make through collaboration. We really enjoyed our visit with Winan van Houdt this week here at Moffitt Cancer Center. Thank you for the outstanding seminars and spending time with our CGSO fellows.

It was a pleasure to be visiting professor at the University of Kansas Health systems. Many thanks to Dr. Luke Selby for having me, discussing treatment or sarcoma and melanoma, and being such a good host!

Great start to CTOS and the day 🤗
at #CTOS2023 opening ceremony

🇮🇪 ☘️ 🎻 💛 #sarcoma

#CTOSTweeTOS CTOS

Can we cure metastatic #sarcoma ?

Winan van Houdt presents nice walk through of cases where cure or long term survival may be possible, variables to help inform decisions, treatment modalities & available data to guide #ESMO23

Looking forward to data coming at #CTOS2023

First day of ESMO lecturing about how we can cure metastatic sarcoma in the educational sarcoma session- not an easy assignment. But good discussion with chair Sylvia Stacchiotti and we learn together along the way

Surgical table at the EORTC dinner, leading the field! Nice time & food after a busy engaging scientific day thanks to the great job of Bernd and ⁦Silvia Stacchiotti⁩ and the team! ⁦CTOS⁩ ⁦Winan van Houdt⁩ ⁦Dirk Strauss⁩ ⁦Sandro Pasquali⁩

On request of dr BK Bakanisi, we donated surgical equipment (omnitract retractor) to the deputy vice chancelor, the vice dean and prof. Allemayehu from the surgery department of the University of Botswana hospital/prinses Marina in Gaborone to facilitate major cancer operations.

Traditional photo at the end of the TARPSWG semiannual meeting & dinner at Society of Surgical Oncology . Thanks everybody who made it to come in person and to all who zoomed in! Another step forward of the global initiative to understand and improve the management of #retroperitoneal #sarcoma

Another virtual EORTC STBSG #sarcoma semi-annual meeting. Good to see so many colleagues on line, but longing to next live meeting in München this year Oct 27 and 28. Winan van Houdt Silvia Stacchiotti @c_messiou Alessandro Gronchi Roger Wilson CBE Ingrid Desar Charlotte Benson Dirk Strauss

Hierbij onze aanmoediging
fb.watch/a_a2icoWvk/ namens het #sarcomen team Antoni van Leeuwenhoek Succes voor alle lopers #hollenvoorHannes Hannes, wàt een bijzondere actie!

⁦ @CTOSSociety is honored to bring together the most brilliant minds in the sarcoma community. It is truly a global society that grows stronger, year after year. Thank you all for making #CTOS2021 a success! See you next year in Vancouver. #ctos2022 #vancouver #togetheragain

Great RPS session @CTOS #CTOS2021 congrats to speakers 👏🏼 Korosh_Khalili Marco Fiore, MD, FACS, FEBSh Dario Callegaro Fabio Tirotta #deannaNg and thoughtful moderators. Making progress, refining care and new hypothesis!!!

#ctos2021 Proud to share outcome ↗️ #retroperitoneal #sarcoma in Istituto Tumori 🇮🇹 since 2002. 1️⃣ increased referral 2️⃣ improved local control (<20% 5yr LR CCI 🔥) 3️⃣ different approach to LPS and LMS 4️⃣ 5-yr Overall Survival ↗️ from 63% to 74%!! Alessandro Gronchi TARPSWG @SoMe4sarcoma

Multidisciplinary Management & Neoadjuvant Therapy

Striking consensus by the multidisciplinary panel supporting Adj/neo Chemotherapy for high risk STS. Additional studies randomizing pts to no chemo would be unethical.

cdmcd.co/ybvvkd #CTOS2021 OncoAlert